Mimedx (MDXG) Receivables Refunds (2018 - 2022)
Mimedx recorded quarterly Receivables Refunds of $704000.0 in Q4 2022, down 6.88% quarter-over-quarter from $756000.0 in Q3 2022, and down 5.25% year-over-year from $743000.0 in Q4 2021.
Mimedx's Receivables Refunds history runs 5 years deep, the most recent figure standing at $704000.0 for Q4 2022.
- In Q4 2022, Receivables Refunds fell 5.25% year-over-year to $704000.0; the TTM figure through Dec 2022 stood at $704000.0 (down 5.25% YoY), while the FY2022 annual figure was $704000.0, down 5.25% from the prior year.
- Receivables Refunds came in at $704000.0 for Q4 2022 at Mimedx, down from $756000.0 in the prior quarter.
- In the past five years, Receivables Refunds ranged from a high of $10.9 million in Q3 2020 to a low of $18000.0 in Q4 2019.
- A 5-year average of $4.1 million and a median of $756000.0 in 2022 frame the typical range for Receivables Refunds.
- Across the five-year window, Receivables Refunds plunged 96.04% in 2019 and surged 55705.56% in 2020, its largest moves.
- Mimedx's Receivables Refunds stood at $454000.0 in 2018, then slumped by 96.04% to $18000.0 in 2019, then soared by 55705.56% to $10.0 million in 2020, then tumbled by 92.6% to $743000.0 in 2021, then declined by 5.25% to $704000.0 in 2022.
- According to Business Quant data, Receivables Refunds over the past three periods registered $704000.0, $756000.0, and $809000.0 for Q4 2022, Q3 2022, and Q2 2022 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Refund Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | - |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | - |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | - |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | - |
| 10 | Mimedx | 530.69 Mn | 370.92 Mn | 41.62 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2022 | 704,000.00 |
| Sep 30, 2022 | 756,000.00 |
| Jun 30, 2022 | 809,000.00 |
| Mar 31, 2022 | 680,000.00 |
| Dec 31, 2021 | 743,000.00 |
| Sep 30, 2021 | 625,000.00 |
| Jun 30, 2021 | 10.14 Mn |
| Mar 31, 2021 | 9.99 Mn |
| Dec 31, 2020 | 10.05 Mn |
| Sep 30, 2020 | 10.85 Mn |
| Jun 30, 2020 | 10.70 Mn |
| Mar 31, 2020 | 10.73 Mn |
| Dec 31, 2019 | 18,000.00 |
| Sep 30, 2019 | 843,000.00 |
| Jun 30, 2019 | 534,000.00 |
| Mar 31, 2019 | 466,000.00 |
| Dec 31, 2018 | 454,000.00 |